Bringing the Oncology Community Together

Dr. Dixon Advises Against Mastectomies

J. Michael Dixon, MBChB, MD
Published Online: Thursday, April 26, 2012


J. Michael Dixon, MBChB, MD, Professor of Surgery, Consultant Surgeon, University of Edinburgh, Clinical Director of the Edinburgh Breast Unit, Western General Hospital, Edinburgh, Scotland, discusses the need to develop a better way of informing women with breast cancer of the potential risks entailed by a mastectomy, including mastectomy with breast reconstruction.

Dixon explains, in the UK approximately 10% of women receiving breast reconstruction following mastectomy experienced a complication that resulted in the loss of their implant. Readmission following mastectomy reaches 10-20%, he notes, this number is exceptionally high when you consider the procedure has not been associated with a reduced rate of local recurrence.

The need for education is an ongoing item, as is the need to increase awareness in the US. Dixon notes, there is currently a large disparity between the UK and the US. He adds that more women in the US are needlessly receiving mastectomy causing additional risks when breast-conserving surgery is the better option.

Related Articles
After years of varying decisions by lower courts regarding the patents held on a test for genetic mutations associated with breast cancer, the US Supreme Court has ruled that a segment of DNA in isolation is a natural product and not eligible for patent protection.
In this segment, the panelists discuss the combination of novel agents with hormonal therapies. To begin the conversation, the BOLERO-2 trial is explored, which looked at the mTOR inhibitor everolimus as a treatment for patients with metastatic breast cancer.
Although recent findings suggest some patients with HER2-negative breast cancer would benefit from therapies directed against overexpression of the protein, two leading oncologists do not see an immediate impact on clinical practice as further validation is needed.
Most Popular Right Now
Physicians' Education Resource
External Resources

American Journal of Managed Care
HCPLive
PainLive
Pharmacy Times
Physicians' Education Resource
Physician's Money Digest
Specialty Pharmacy Times
TargetedHC
OncLive Resources

Archives
Blogs
OncLive TV
Oncology Nurses
Publications
Specialties
Web Exclusives


About Us
Advertise
Advisory Board
Contact Us
Forgot Password
Privacy Policy
Terms & Conditions
Intellisphere, LLC
666 Plainsboro Road
Building 300
Plainsboro, NJ 08536
P: 609-716-7777
F: 609-716-4747

Copyright OncLive 2006-2013
Intellisphere, LLC. All Rights Reserved.